Brief: Cyxone Orders More Rabeximod Substance And Confirms Timeline For Phase IIb

Cyxone AB

29/01/2020 09:01

Jan 29 (Reuters) - Cyxone AB  CYXO.ST :
    * CYXONE ORDERS MORE RABEXIMOD SUBSTANCE AND CONFIRMS
TIMELINE FOR
THE PHASE IIB PROGRAM
    * CYXONE AB - AN ORDER OF MORE RABEXIMOD SUBSTANCE WILL BE
PLACED
EARLIER THAN EXPECTED WITH PRIMARY OBJECTIVE OF PROVIDING
OPTIMAL CONDITIONS FOR CONDUCTING CLINICAL PHASE IIB TRIAL
    * CYXONE AB - AS A RESULT, FIRST PATIENT IS EXPECTED TO
ENTER
CLINICAL PHASE IIB TRIAL IN Q1 OF 2021

Source text for Eikon:  ID:nWkr9L9QrN 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))